134P Comprehensive assessment of anti-tumour PDL1 blockade effect in a sarcoma mouse model

ConclusionAltogether, this multiparametric dataset gives i) a better understanding of intrinsic features of the preclinical model and deeper insights into the mechanism of action of an effective drug, and ii) might serve as a platform combination-based strategy for comprehensive explorations of novel candidates.Legal entity responsible for the studyAlban Bessede.FundingExplicyte Immuno-Oncology.DisclosureA. Bessede: Shareholder / Stockholder / Stock options, Full / Part-time employment: Explicyte. All other authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research